FDA Inspection
Pfizer, Inc.Pfizer, Inc. – FDA Inspection, Dec 13, 2024
Record Details
This FDA Inspection record concerns Pfizer, Inc., with an inspection on December 13, 2024, issued by the New England District Office, covering human drugs.
View Company Profile
ID · d45be9cf-ef2e-4d2d-9638-08e91b31a22c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256477
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 58.130(a)Conduct: in accordance with protocol
- 21 CFR 58.33(f)Study director: transfer of data to archives
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pfizer, Inc.
25| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2025 | Not classified | New England District Office | |
| August 30, 2024 | Not classified | New England District Office | |
| July 19, 2024 | Not classified | New England District Office | |
| April 19, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 28, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Pfizer, Inc.
- FDA Inspection 1284680 - 2025-10-24
- FDA Inspection 1249289 - 2024-08-30
- FDA Inspection 1230476 - 2024-07-19
- FDA Inspection 1204434 - 2023-04-19
- FDA Inspection 1190580 - 2022-10-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.